Balasa Dinverno & Foltz’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $316K | Buy |
6,338
+60
| +1% | +$2.99K | 0.02% | 264 |
|
|
2022
Q2 | $350K | Buy |
6,278
+58
| +0.9% | +$3.23K | 0.02% | 244 |
|
|
2022
Q1 | $345K | Sell |
6,220
-126
| -2% | -$6.99K | 0.02% | 246 |
|
|
2021
Q4 | $355K | Buy |
6,346
+126
| +2% | +$7.05K | 0.02% | 242 |
|
|
2021
Q3 | $299K | Buy |
6,220
+218
| +4% | +$10.5K | 0.02% | 256 |
|
|
2021
Q2 | $251K | Buy |
+6,002
| New | +$251K | 0.02% | 289 |
|